Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 7.17M | $107.0M | 8.52% | -- | 2026-06-30 |
| BlackRock, Inc. | 7.14M | $106.0M | 8.49% | +978.4K | 2026-06-30 |
| STATE STREET CORP | 4.47M | $66.0M | 5.32% | +908.1K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.79M | $56.0M | 4.50% | +871.8K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.29M | $49.0M | 3.91% | +58.2K | 2026-06-30 |
| ADAMS STREET PARTNERS LLC | 3.28M | $48.0M | 3.89% | -- | 2026-06-30 |
| Vivo Capital, LLC | 2.81M | $41.0M | 3.34% | -- | 2026-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.73M | $40.0M | 3.25% | +413.1K | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 2.67M | $39.0M | 3.17% | +375.0K | 2026-06-30 |
| Deep Track Capital, LP | 2.49M | $37.0M | 2.96% | +400 | 2026-06-30 |
